ASX - By Stock
|
TSO |
Re:
Ann: Vast continuous gold anomalism confirmed at El Zorro Project
|
|
YunKL3
|
18 |
11K |
3 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
18
|
11K
|
3
|
|
ASX - By Stock
|
TSO |
Re:
Ann: Vast continuous gold anomalism confirmed at El Zorro Project
|
|
YunKL3
|
18 |
11K |
0 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
18
|
11K
|
0
|
|
ASX - By Stock
|
TSO |
Re:
Ann: Vast continuous gold anomalism confirmed at El Zorro Project
|
|
YunKL3
|
18 |
11K |
1 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
18
|
11K
|
1
|
|
ASX - By Stock
|
ZIP |
Can we get Larry on the phone???
|
|
YunKL3
|
0 |
1.0K |
0 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
0
|
1.0K
|
0
|
|
ASX - By Stock
|
VMS |
Re:
News: VMS Venture Minerals Seeks Trading Halt
|
|
YunKL3
|
5 |
1.8K |
0 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
5
|
1.8K
|
0
|
|
ASX - By Stock
|
TKM |
Re:
Ann: Trading Halt
|
|
YunKL3
|
15 |
6.6K |
0 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
15
|
6.6K
|
0
|
|
ASX - By Stock
|
XAM |
Re:
Ann: High Impact Drilling Programme at Kharmagtai
|
|
YunKL3
|
4 |
1.8K |
5 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
4
|
1.8K
|
5
|
|
ASX - By Stock
|
APX |
Re:
Ann: Retail Entitlement Offer Opens & Despatch of Offer Booklet
|
|
YunKL3
|
82 |
41K |
0 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
82
|
41K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Capital Raising & Debt Repayment
|
|
YunKL3
|
23 |
10K |
7 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
23
|
10K
|
7
|
|
ASX - By Stock
|
APX |
Re:
Ann: Strategy refresh and capital raising presentation
|
|
YunKL3
|
116 |
44K |
4 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
116
|
44K
|
4
|
|
ASX - By Stock
|
EMU |
Re:
Ann: REE Discovery Viper Project Jerramungup WA
|
|
YunKL3
|
18 |
9.8K |
0 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
18
|
9.8K
|
0
|
|
ASX - By Stock
|
BRK |
Re:
Ann: Wolf Pack Tops Brookside Production Rankings
|
|
YunKL3
|
67 |
23K |
38 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
67
|
23K
|
38
|
|
ASX - By Stock
|
LGM |
Re:
Ann: Drilling Assays Confirm New Epithermal Discovery at Bauloora
|
|
YunKL3
|
21 |
6.4K |
1 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
21
|
6.4K
|
1
|
|
ASX - By Stock
|
AKO |
Re:
Ann: AKORA InvestorHub
|
|
YunKL3
|
3 |
884 |
6 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
3
|
884
|
6
|
|
ASX - By Stock
|
HMG |
Re:
Ann: Trading Halt
|
|
YunKL3
|
8 |
2.4K |
0 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
8
|
2.4K
|
0
|
|
ASX - By Stock
|
VUL |
Re:
Ann: Trading Halt
|
|
YunKL3
|
8 |
4.1K |
0 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
8
|
4.1K
|
0
|
|
ASX - By Stock
|
PWN |
Re:
Ann: Launch of Parkway Investor Hub
|
|
YunKL3
|
22 |
12K |
9 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
22
|
12K
|
9
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Appendix 4D and Half Year Financial Report
|
|
YunKL3
|
148 |
40K |
3 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
148
|
40K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
YunKL3
|
10 |
5.2K |
6 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
10
|
5.2K
|
6
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: AR9 Awarded Contract with DHL Information Services
|
|
YunKL3
|
28 |
6.5K |
0 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
28
|
6.5K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Trading Halt
|
|
YunKL3
|
20 |
6.5K |
0 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
20
|
6.5K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Trading Halt
|
|
YunKL3
|
20 |
6.5K |
1 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
20
|
6.5K
|
1
|
|
ASX - By Stock
|
IPT |
Re:
Ann: Trading Halt
|
|
YunKL3
|
30 |
12K |
2 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
30
|
12K
|
2
|
|
ASX - By Stock
|
IPT |
Re:
Ann: Trading Halt
|
|
YunKL3
|
30 |
12K |
1 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
30
|
12K
|
1
|
|
ASX - By Stock
|
ATC |
Re:
Ann: Altech - Investor Presentation by CEO Singapore Conference
|
|
YunKL3
|
3 |
2.6K |
3 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
3
|
2.6K
|
3
|
|
ASX - By Stock
|
BIO |
Re:
Ann: Quarterly Activities & Cashflow Report
|
|
YunKL3
|
15 |
3.5K |
2 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
15
|
3.5K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ethics Approval to Start Phase I/II (I.V.) Clinical Trial
|
|
YunKL3
|
35 |
16K |
4 |
18/04/23 |
18/04/23 |
ASX - By Stock
|
35
|
16K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ethics Approval to Start Phase I/II (I.V.) Clinical Trial
|
|
YunKL3
|
35 |
16K |
9 |
18/04/23 |
18/04/23 |
ASX - By Stock
|
35
|
16K
|
9
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ethics Approval to Start Phase I/II (I.V.) Clinical Trial
|
|
YunKL3
|
35 |
16K |
9 |
18/04/23 |
18/04/23 |
ASX - By Stock
|
35
|
16K
|
9
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ethics Approval to Start Phase I/II (I.V.) Clinical Trial
|
|
YunKL3
|
35 |
16K |
9 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
35
|
16K
|
9
|
|
ASX - By Stock
|
BIO |
Re:
Ann: 'Biome delivers record quarterly sales in Q3 FY23
|
|
YunKL3
|
27 |
6.4K |
7 |
13/04/23 |
13/04/23 |
ASX - By Stock
|
27
|
6.4K
|
7
|
|
ASX - By Stock
|
ADR |
Re:
Does ADR understand their market ?
|
|
YunKL3
|
73 |
20K |
7 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
73
|
20K
|
7
|
|
ASX - By Stock
|
TSO |
Re:
Ann: Investor Presentation
|
|
YunKL3
|
27 |
12K |
3 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
27
|
12K
|
3
|
|
ASX - By Stock
|
TSO |
Re:
Ann: Investor Presentation
|
|
YunKL3
|
27 |
12K |
0 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
27
|
12K
|
0
|
|
ASX - By Stock
|
AQC |
Re:
Ann: Quarterly Activities and Cashflow Reports
|
|
YunKL3
|
6 |
6.0K |
1 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
6
|
6.0K
|
1
|
|
ASX - By Stock
|
TSO |
Re:
Ann: Investor Presentation
|
|
YunKL3
|
27 |
12K |
1 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
27
|
12K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial
|
|
YunKL3
|
70 |
23K |
4 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
70
|
23K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Leadership Changes
|
|
YunKL3
|
559 |
179K |
7 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
559
|
179K
|
7
|
|
ASX - By Stock
|
TNY |
Re:
Ann: Tinybeans Launches new Interactive Investor Hub
|
|
YunKL3
|
2 |
1.5K |
2 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
2
|
1.5K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
News: EYE Nova Eye Medical Seeks Trading Halt
|
|
YunKL3
|
8 |
2.8K |
1 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
8
|
2.8K
|
1
|
|